Dr. Zhavoronkov is a biogerontologist and artificial intelligence  scientist with deep passion for longevity science and industry He is  the founder of Insilico Medicine, longevity and artificial intelligence company which raised over $51 million from the worlds most competent investors He invented several critical artificial intelligence technologies in drug discovery and biomarkers of aging and established collaborations with the top pharmaceutical companies.  Dr. Zhavoronkov is the author of over 150 research papers published since 2011 and books including “Ageless Generation” a book on aging  economics published by McMillan in 2013 His recent Nature paper demonstrated that artificial intelligence can be used to create new molecules with experimental validation in animals in under 46 days.